Evolocumab is Initiated in Central and Eastern Europe at Much Higher LDL-C Levels Than Recommended in Guidelines: Results from the Observational HEYMANS Study.

导出 LinkOut

翻译打印收藏纠错

第一作者： Vladimír,Blaha

第一单位： 3rd Department of Internal Medicine - Metabolic Care and Gerontology, University Hospital Hradec Kralove and Charles University, Hradec Kralove, Czech Republic.

作者： Vladimír,Blaha ^[1] ; Roman,Margoczy ^[2] ; Ivo,Petrov ^[3] ; Arman,Postadzhiyan ^[4] ; Katarína,Rašlová ^[5] ; Hana,Rosolová ^[6] ; Ian,Bridges ^[7] ; Nafeesa N,Dhalwani ^[8] ; Marie,Zachlederova ^[9] ; Kausik K,Ray ^[10]

作者单位： 3rd Department of Internal Medicine - Metabolic Care and Gerontology, University Hospital Hradec Kralove and Charles University, Hradec Kralove, Czech Republic. ^[1] Department of General Cardiology, Middle Slovak Institute of Cardiovascular Diseases, Banska Bystrica, Slovakia. ^[2] Department of Cardiology, Clinic of Cardiology and Angiology, University Hospital Acibadem City Clinic and Sofia University "St. Kliment Ohridski", Sofia, Bulgaria. ^[3] Department of General Medicine, Medical University of Sofia, Sofia, Bulgaria. ^[4] Metabolic Center, LTD, Bratislava, Slovakia. ^[5] 2nd Medical Department, Center of Preventive Cardiology, Charles University of Pilsen, Pilsen, Czechia. ^[6] Amgen Ltd, Uxbridge, UK. ^[7] Amgen Inc., Thousand Oaks, USA. ^[8] JCPT1172847Amgen s.r.o., Prague, Czech Republic. ^[9] Department of Public Health and Primary Care, Imperial Centre for Cardiovascular Disease Prevention and Imperial Clinical Trials Unit, Imperial College London, London, UK. ^[10]

关键词 LDL-C PCSK9i cardiovascular risk evolocumab guidelines

主题词人类(Humans);抗胆固醇血症药(Anticholesteremic Agents);胆固醇, LDL(Cholesterol, LDL);欧洲, 东部(Europe, Eastern);羟甲基戊二酰基CoA还原酶抑制剂(Hydroxymethylglutaryl-CoA Reductase Inhibitors);治疗结果(Treatment Outcome)

DOI 10.1177/10742484231172847

PMID 37218974

发布时间 2023-06-13

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交

浏览0

Journal of cardiovascular pharmacology and therapeutics

10742484231172847页

相似文献

中文期刊
外文期刊
学位论文
会议论文

检索历史清除

Evolocumab is Initiated in Central and Eastern Europe at Much Higher LDL-C Levels Than Recommended in Guidelines: Results from the Observational HEYMANS Study.

Journal of cardiovascular pharmacology and therapeutics

相似文献

Journal of cardiovascular pharmacology and therapeutics

相关期刊

参考文献：
指定格式：	NoteExpress EndNote RefWorks NoteFirst

检索历史 清除

Evolocumab is Initiated in Central and Eastern Europe at Much Higher LDL-C Levels Than Recommended in Guidelines: Results from the Observational HEYMANS Study.

Journal of cardiovascular pharmacology and therapeutics

相似文献

Journal of cardiovascular pharmacology and therapeutics

相关期刊

检索历史清除